Product
Lipid-lowering therapy combination with PCSK9 inhibitors, bempedoic acid and ezetimibe
1 clinical trial
4 indications
Indication
DyslipidemiaIndication
Statin Adverse ReactionIndication
Cardiovascular DiseasesIndication
Lipid Metabolism DisordersClinical trial
Efficacy and Safety of Bempedoic Acid in Association With Anti-PCSK9 and Ezetimibe in Statin-intolerant Patients: a Randomized Crossover TrialStatus: Not yet recruiting, Estimated PCD: 2025-06-30